Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients

The Cochrane Database of Systematic Reviews
A C FordP Moayyedi

Abstract

Peptic ulcer disease is the cause for dyspepsia in about 10% of patients. 95% of duodenal and 70% of gastric ulcers are associated with Helicobacter pylori. Eradication of H pylori reduces the relapse rate of ulcers but the magnitude of this effect is uncertain. The primary outcomes were the proportion of peptic ulcers healed initially and proportion of patients free from relapse following successful healing. Eradication therapy was compared to placebo or pharmacological therapies in H. pylori positive patients. Secondary aims included symptom relief and adverse effects. Searches were conducted on the Cochrane Central register of Controlled Trials - CENTRAL (which includes the Cochrane Upper Gastrointestinal and Pancreatic Diseases Group Trials Register) on The Cochrane Library (Issue 3 2002) MEDLINE (1966 to July 2002) and EMBASE (1980 to July 2002). Reference lists from trials selected by electronic searching were handsearched to identify further relevant trials. Published abstracts from conference proceedings from the United European Gastroenterology Week (published in Gut) and Digestive Disease Week (published in Gastroenterology) were handsearched. The search was updated in September 2003, November 2004 and November 2005. ...Continue Reading

Citations

Feb 27, 2007·Journal of Gastroenterology·Hidekazu SuzukiBarry James Marshall
Aug 2, 2012·The Indian Journal of Surgery·Jagmohan Mishra, Souvagya Panigrahi
Feb 25, 2011·World Journal of Emergency Surgery : WJES·Nicole LopezRaul Coimbra
Sep 13, 2012·World Journal of Gastroenterology : WJG·Giuliana SereniRomano Sassatelli
Feb 23, 2013·World Journal of Gastroenterology : WJG·Angelo ZulloVincenzo Bruzzese
Aug 26, 2014·World Journal of Gastroenterology : WJG·Antonio RollanArnoldo Riquelme
Feb 8, 2016·The Cochrane Database of Systematic Reviews·Qian RenWei Xin Li
Dec 18, 2013·The Cochrane Database of Systematic Reviews·Yuhong YuanPaul Moayyedi
Sep 1, 2008·Therapeutic Advances in Gastroenterology·Yi-Chia LeeJaw-Town Lin
Aug 2, 2017·Journal of Gastroenterology and Hepatology·Varocha MahachaiDavid Graham
Mar 23, 2010·Helicobacter·Masahiro AsakaUNKNOWN Japanese Society for Helicobacter Research
Aug 24, 2006·Helicobacter·Tamara Matysiak-BudnikStanislas Chaussade
Oct 19, 2006·Journal of the National Cancer Institute·Olof Nyrén, William J Blot
Nov 23, 2006·International Journal of Hematology·Hidekazu SuzukiToshifumi Hibi
Apr 20, 2016·The Cochrane Database of Systematic Reviews·Alexander C FordPaul Moayyedi
May 15, 2016·Current Gastroenterology Reports·Elizabeth A MarcusDavid R Scott
Oct 4, 2019·BMJ : British Medical Journal·Emma SverdénJesper Lagergren
Feb 11, 2020·Frontiers in Pediatrics·Yasufumi SakataShunji Hasegawa
Jun 14, 2019·Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva·Shirley Pérez RomeroJoaquín León Molina
Jun 5, 2014·ANZ Journal of Surgery·Cameron G RobertsonDavid I Watson
Dec 30, 2009·Deutsches Ärzteblatt International·Wolfgang FischbachUNKNOWN Association of Scientific Medical Societies
Jul 18, 2020·Gastroenterología y hepatología·José Andrés Alcaraz SerratGloria Fernández-Esparrach
Sep 29, 2011·Gastrointestinal Endoscopy Clinics of North America·Andrew Y Wang, David A Peura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Related Papers

The Cochrane Database of Systematic Reviews
P MoayyediD Forman
The American Journal of Gastroenterology
J P GisbertH. pylori Study Group of the Asociación Española de Gastroenterología (Spanish Gastroenterology Association)
© 2022 Meta ULC. All rights reserved